MGAT1 and cancer: Although loss of GnT-I (or mutations in MGAT1) are not common in NB or cancer, functional loss of GnT-I, here achieved by CRISPR/Cas9 knockout of MGAT1, is a highly efficient approach to produce cells or organisms greatly enriched in oligomannose N-glycans.